4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0001193125-25-314735
Director sold 16,115 shares at an average $13.48 ($217,297)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CORRIGAN MARK · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Sale : show line 1 in the form 10b5-1 | −9,600 | $13.09 | $125,664 | 35,330 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −6,515 | $14.07 | $91,633 | 28,815 | D |
| Open-market sales · 16,115 sh · avg $13.48 · $217,297 | ||||||
Loading xslF345X05/ownership.xml…